SIACharts Logo

Moderna Inc. (MRNA)

Reflecting a rotation into defensive health care stocks, and responding to positive clinical trial news, vaccine producer Moderna (MRNA) jumped 30 spots in the SIA S&P 500 Index Report yesterday to 13th place. The shares have been climbing back up the rankings since October and since they returned to the Green Favored Zone in early November, they have returned 27.3%.

Gold Continuous Contract (GC.F) & BMO China Equity Index ETF (ZCH.TO)

In this edition of the Equity Leaders Weekly, we look at the impact of the weakening US Dollar on Gold and at a rebound in Chinese equity markets as the country’s COVID policy changes.

Keep up to date on the latest financial market news.

Receive a daily newsletter with stock highlights, ETF rankings, weekly market focus and others.